Results 211 to 220 of about 634,068 (304)

Emotional Well-Being and Glycemic Control in People with Diabetes After a Multidisciplinary Hybrid Education. [PDF]

Healthcare (Basel)
Ruiz-Trillo CA, Pérez-Morales A, Cortés-Lerena A, Cruz-Álvarez PS, Enríquez-Macias M, Pabón-Carrasco M, Garrido-Bueno M, Romero-Castillo R, Bellido V.   +8 more
europepmc   +1 more source

The Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost among Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients: A Population‐based Study

Arthritis &Rheumatology, Accepted Article.
Objective To assess the association between early antimalarial adherence and future acute care utilization and cost in a population‐based cohort of incident rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Methods All patients with incident RA/SLE and new antimalarial use in British Columbia, Canada, between 01/1997 and 03/2022 with at
Md Rashedul Hoque, Diane Lacaille, J Antonio Aviña‐Zubieta, Mary A De Vera, Yi Qian, Lawrence McCandless, John M Esdaile, Hui Xie   +7 more
wiley   +1 more source

Therapeutic Potential of Holothuria leucospilota Extract in STZ-Induced Diabetic Rats: Targeting Inflammation and Apoptosis at the Gene Expression Level. [PDF]

Endocrinol Diabetes Metab
Darbandi N, Al-Rikabi MY.
europepmc   +1 more source

The Relationship Between Aldose Reductase and Isoxazole Derivatives: An In Vitro and In Silico Approach to Its Correlation With Diabetic Conditions

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Diabetes mellitus (DM), which can result in a number of problems such as cataracts, neuropathy, retinopathy, nephropathy, and several cardiovascular illnesses, continues to be a growing issue despite major advancements in treatment approaches.
Ahmet Esat Göner, Hatice Esra Duran
wiley   +1 more source

Improving self-care, HbA1c control, and quality of life in type 2 diabetes: a self-regulation intervention based on the individual and family self-management theory. [PDF]

Front Clin Diabetes Healthc
Fadli F, Nursalam N, Sjattar EL, Uly N.
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Bioinformatics study of the pharmacological mechanism of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus and coronary heart disease based on network pharmacology. [PDF]

Medicine (Baltimore)
Yu S, Li J, Wu X, Lu S, Li C, Cheng H, Guo H, Yang P, Wang L.   +8 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source